当前位置:
X-MOL 学术
›
J. Nat. Prod.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Cyclizidine-Type Alkaloids from Streptomyces sp. HNA39
Journal of Natural Products ( IF 3.3 ) Pub Date : 2018-02-01 00:00:00 , DOI: 10.1021/acs.jnatprod.7b01055 Yong-Jun Jiang 1 , Jia-Qi Li 1 , Hao-Jian Zhang 1 , Wan-Jing Ding 1 , Zhong-Jun Ma 1
Journal of Natural Products ( IF 3.3 ) Pub Date : 2018-02-01 00:00:00 , DOI: 10.1021/acs.jnatprod.7b01055 Yong-Jun Jiang 1 , Jia-Qi Li 1 , Hao-Jian Zhang 1 , Wan-Jing Ding 1 , Zhong-Jun Ma 1
Affiliation
Eight new cyclizidine-type alkaloids (1–8) and one known alkaloid (9) were identified from the chemical investigations of a marine-derived actinomycete, Streptomyces sp. HNA39. Among these alkaloids, compounds 3, 7, and 8 contain a chlorine atom, and the known alkaloid, (+)-ent-cyclizidine (9), is now first reported as a natural product. Their structures were elucidated by extensive NMR-spectroscopic analysis and HRESIMS data. The absolute configurations of all of the compounds were established by ECD calculations. Cytotoxicity evaluations of all of the compounds showed that compound 2 exhibited significant activity against the PC3 and HCT116 human-cancer-cell lines with IC50 values of 0.52 ± 0.03 and 8.3 ± 0.1 μM, respectively. Interestingly, compounds 2, 5, 7, and 8 exhibited moderate inhibition against the ROCK2 protein kinase with IC50 values from 7.0 ± 0.8 to 42 ± 3 μM.
中文翻译:
链霉菌属的环丙啶类生物碱。HNA39
从海洋衍生的放线菌(Streptomyces sp。)的化学研究中鉴定出八种新的环偶氮型生物碱(1 – 8)和一种已知的生物碱(9)。海航39。在这些生物碱,化合物3,7,和8含有一个氯原子,和已知的生物碱,(+) - ENT -cyclizidine(9),现在首次报道作为天然产物。通过广泛的NMR光谱分析和HRESIMS数据阐明了它们的结构。通过ECD计算确定所有化合物的绝对构型。所有化合物的细胞毒性评估表明,化合物2表现出对PC3和HCT116人癌细胞系的显着活性,IC 50值分别为0.52±0.03和8.3±0.1μM。有趣的是,化合物2,5,7,和8表现出对与IC的ROCK2蛋白激酶抑制适中50值从7.0±0.8至42±3微米。
更新日期:2018-02-01
中文翻译:
链霉菌属的环丙啶类生物碱。HNA39
从海洋衍生的放线菌(Streptomyces sp。)的化学研究中鉴定出八种新的环偶氮型生物碱(1 – 8)和一种已知的生物碱(9)。海航39。在这些生物碱,化合物3,7,和8含有一个氯原子,和已知的生物碱,(+) - ENT -cyclizidine(9),现在首次报道作为天然产物。通过广泛的NMR光谱分析和HRESIMS数据阐明了它们的结构。通过ECD计算确定所有化合物的绝对构型。所有化合物的细胞毒性评估表明,化合物2表现出对PC3和HCT116人癌细胞系的显着活性,IC 50值分别为0.52±0.03和8.3±0.1μM。有趣的是,化合物2,5,7,和8表现出对与IC的ROCK2蛋白激酶抑制适中50值从7.0±0.8至42±3微米。